Abstract
Introduction
PBC registries in the UK focus on data from secondary care without clear coordinated contribution from primary care. The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) receives data from > 500 primary care practices (PCPs). Notably, the Lancet commissioning group is extracting data from the RCGP RSC database to shape UK policy on liver disease.
Aims
To create a novel ontology to facilitate PBC case finding from primary care provider (PCP) records.
Methods
RCGP RSC data were collected from participating PCPs in the county of Surrey, UK. PBC diagnostic criteria of the AASLD and EASL guidelines were used to develop 725 data codes to facilitate patient record searches. A scoring system built into the ontology allowed categorization of cases as PBC definite, PBC probable, and PBC unlikely.
Results
A total of 218,099 records were searched from participating PCPs. Of these, there were 58 PBC definite, 2317 PBC probable, and 215,724 PBC unlikely patients. There were 32 PBC definite patients who did not match to our regional PBC database and were henceforth included as new-found cases. Two of these cases were not labeled as PBC by the PCP. From the PBC unlikely group, 7/215,724 (0.003%) patients were labeled as PBC in secondary care records; however, none of them were coded as having PBC by their PCPs.
Conclusions
Utilization of the UK National RCGP RSC database supported by novel ontology score has successfully helped us identify (i) new cases of PBC not known to local/regional secondary care providers and (ii) de novo PBC cases. There are many PBC probable cases whose data merit further careful evaluation.
Similar content being viewed by others
References
Williams R, Aspinall R, Bellis M, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384:1953–1997. https://doi.org/10.1016/S0140-6736(14)61838-9.
Williams R, Alexander G, Aspinall R, et al. Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2018;392:2398–2412. https://doi.org/10.1016/S0140-6736(18)32561-3.
Griffiths L, Dyson JK, Jones DE. The new epidemiology of primary biliary cirrhosis. Semin Liver Dis. 2014;34:318–328. https://doi.org/10.1055/s-0034-1383730.
Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56:1181–1188. https://doi.org/10.1016/j.jhep.2011.10.025.
Kim KA, Ki M, Choi HY, Kim BH, Jang ES, Jeong SH. Population-based epidemiology of primary biliary cirrhosis in South Korea. Aliment Pharmacol Ther. 2016;43:154–162. https://doi.org/10.1111/apt.13448.
Correa A, Hinton W, McGovern A, et al. Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile. BMJ Open. 2016;6:e011092. https://doi.org/10.1136/bmjopen-2016-011092.
de Lusignan S. Codes, classifications, terminologies and nomenclatures: definition, development and application in practice. Inform Prim Care. 2005;13:65–70.
Haendel MA, Chute CG, Robinson PN. Classification, ontology, and precision medicine. N Engl J Med. 2018;379:1452–1462. https://doi.org/10.1056/NEJMra1615014.
Mouillet G, Monnet E, Milleron B, et al. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol. 2012;7:841–849. https://doi.org/10.1097/JTO.0b013e31824c7d92.
Hu FL, Cheng H, Zhang XZ, et al. Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study. Zhonghua Yi Xue Za Zhi. 2012;92:679–684.
Wagner CL, McNeil RB, Johnson DD, et al. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol. 2013;136:313–320. https://doi.org/10.1016/j.jsbmb.2013.01.002.
Sheridan SL, Golin C, Bunton A, et al. Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012;12:130. https://doi.org/10.1186/1472-6947-12-130.
Royal College of General Practitioners. Liver disease toolkit. 2017. http://www.rcgp.org.uk/clinical-and-research/toolkits/liver-disease-toolkit.aspx. Accessed 13/12/2017.
Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007;46:1131–1137. https://doi.org/10.1002/hep.21795.
Varyani FK, West J, Card TR. An increased risk of urinary tract infection precedes development of primary biliary cirrhosis. BMC Gastroenterol. 2011;11:95. https://doi.org/10.1186/1471-230X-11-95.
Varyani FK, West J, Card TR. Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases? Liver Int. 2013;33:384–388. https://doi.org/10.1111/liv.12107.
Solaymani-Dodaran M, Aithal GP, Card T, West J. Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study. Am J Gastroenterol. 2008;103:2784–2788. https://doi.org/10.1111/j.1572-0241.2008.02092.x.
Solaymani-Dodaran M, Card TR, Aithal GP, West J. Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology. 2006;131:1752–1757. https://doi.org/10.1053/j.gastro.2006.09.012.
Varyani F, Card T, Kaye P, Aithal GP, West J. The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioners: a population-based study. BMC Health Serv Res. 2013;13:161. https://doi.org/10.1186/1472-6963-13-161.
Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008;48:939–944. https://doi.org/10.1016/j.jhep.2008.02.017.
Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: a general population-based study. J Hepatol. 2008;49:732–738. https://doi.org/10.1016/j.jhep.2008.05.023.
Crooks CJ, West J, Solaymani-Dodaran M, Card TR. The epidemiology of haemochromatosis: a population-based study. Aliment Pharmacol Ther. 2009;29:183–192. https://doi.org/10.1111/j.1365-2036.2008.03874.x.
Grainge MJ, West J, Solaymani-Dodaran M, Aithal GP, Card TR. The antecedents of biliary cancer: a primary care case-control study in the United Kingdom. Br J Cancer. 2009;100:178–180. https://doi.org/10.1038/sj.bjc.6604765.
Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. 2010;32:1343–1350. https://doi.org/10.1111/j.1365-2036.2010.04473.x.
Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. 2012;32:79–84. https://doi.org/10.1111/j.1478-3231.2011.02517.x.
Ratib S, Fleming KM, Crooks CJ, Aithal GP, West J. 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study. J Hepatol. 2014;60:282–289. https://doi.org/10.1016/j.jhep.2013.09.027.
Ratib S, West J, Crooks CJ, Fleming KM. Diagnosis of liver cirrhosis in England, a cohort study, 1998-2009: a comparison with cancer. Am J Gastroenterol. 2014;109:190–198. https://doi.org/10.1038/ajg.2013.405.
Ratib S, West J, Fleming KM. Liver cirrhosis in England-an observational study: are we measuring its burden occurrence correctly? BMJ Open. 2017;7:e013752. https://doi.org/10.1136/bmjopen-2016-013752.
West J, Card TR, Aithal GP, Fleming KM. Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study. Aliment Pharmacol Ther. 2017;45:983–990. https://doi.org/10.1111/apt.13961.
Crooks CJ, West J, Jepsen P. A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink. Clin Epidemiol. 2018;10:107–120. https://doi.org/10.2147/CLEP.S147535.
European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–172. https://doi.org/10.1016/j.jhep.2017.03.022.
Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394–419. https://doi.org/10.1002/hep.30145.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br J Cancer. 2015;112:251–259. https://doi.org/10.1038/bjc.2014.639.
Cole NI, Liyanage H, Suckling RJ, et al. An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study. BMC Nephrol. 2018;19:85. https://doi.org/10.1186/s12882-018-0882-9.
de Lusignan S, Shinneman S, Yonova I, et al. An ontology to improve transparency in case definition and increase case finding of infectious intestinal disease: database study in english general practice. JMIR Med Inform. 2017;5:e34. https://doi.org/10.2196/medinform.7641.
Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342:1266–1271. https://doi.org/10.1056/NEJM200004273421707.
Donnan PT, McLernon D, Steinke D, et al. Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE). BMC Health Serv Res. 2007;7:54. https://doi.org/10.1186/1472-6963-7-54.
Donnan PT, McLernon D, Dillon JF, Ryder S, Roderick P, Sullivan F et al. Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). Health Technol Assess. 2009;13(25):iii-iv, ix-xi, 1-134. https://doi.org/10.3310/hta13250.
Liyanage H, Krause P, De Lusignan S. Using ontologies to improve semantic interoperability in health data. J Innov Health Inform. 2015;22:309–315. https://doi.org/10.14236/jhi.v22i2.159.
Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med. 2015;3:377–387. https://doi.org/10.1016/S2213-2600(15)00139-3.
Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–1511. https://doi.org/10.1056/NEJMoa1306555.
Kohler S, Vasilevsky NA, Engelstad M, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45:D865–D876. https://doi.org/10.1093/nar/gkw1039.
Kohler S, Schulz MH, Krawitz P, et al. Clinical diagnostics in human genetics with semantic similarity searches in ontologies. Am J Hum Genet. 2009;85:457–464. https://doi.org/10.1016/j.ajhg.2009.09.003.
Pericleous M, Kelly C, De Lusignan S, Ala A, editors. Developing a novel real-world south east England registry for primary biliary cholangitis (PBC) allowing data-linkage from primary to secondary care-preliminary findings from a UK national institute for health research (NIHR) portfolio study. Hepatology; 2018: Wiley 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.
Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF. The epidemiology of liver disease in Tayside database: a population-based record-linkage study. J Biomed Inform. 2002;35:186–193.
Sherwood P, Lyburn I, Brown S, Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. BMJ. 2001;322:276–278.
Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67:6–19. https://doi.org/10.1136/gutjnl-2017-314924.
Ala A, Stanca CM, Bu-Ghanim M, et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology. 2006;43:525–531. https://doi.org/10.1002/hep.21076.
Dyson J, Shirley M, Blain A, Hudson M, Rushton S, Jones D. Disease clustering in autoimmune liver diseases points towards environmental factors being important in their aetiology. J Hepatol. 2019;70:e11–e12.
Acknowledgments
We are grateful to the support of the international Practice to Policy program (Intercept pharmaceuticals), the British Liver Trust, the Primary Biliary Cholangitis (PBC) foundation, the Royal College of General Practitioners (RCGP), the patients and practices of the RCGP RSC network, Health Research Authority (HRA) for granting ethics and confidentiality advisory group approvals (reference 16/LO/2145), and the National Institute for Health Research (NIHR) of the UK for including this project in the national portfolio of recruiting studies (portfolio ID 33049). We are particularly thankful to John Williams, Rachel Byford, Harshana Liyanage, and Filipa Ferreira of the RCGP RSC for their valuable contribution.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pericleous, M., Kelly, C., Odin, J.A. et al. Clinical Ontologies Improve Case Finding of Primary Biliary Cholangitis in UK Primary and Secondary Care. Dig Dis Sci 65, 3143–3158 (2020). https://doi.org/10.1007/s10620-019-06039-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-06039-x